Skip to main content
. 2014 Jun 10;14:419. doi: 10.1186/1471-2407-14-419

Table 1.

Clinical characteristics of 5-year survivors of acute lymphoblastic leukemia

  ALL survivors
Chemotherapy only
CRT
TBI
n = 213 % n = 104 % n = 95 % n = 14 %
Age at diagnosis
 
 
 
 
 
 
 
 
  <5 yrs
111
52.1
61
58.7
45
47.4
5
35.7
  5-9 yrs
71
33.3
34
32.7
33
34.7
4
28.6
  10-17 yrs
31
14.6
9
8.7
17
17.9
5
35.7
Period of diagnosis
 
 
 
 
 
 
 
 
  1970-1979
42
19.7
3
2.9
39
41.1
0
0
  1980-1989
78
36.6
39
37.5
32
33.7
7
50.0
  1990-1999
93
43.7
62
59.6
24
25.3
7
50.0
Age at end of follow-up
 
 
 
 
 
 
 
 
  10-19 yrs
54
25.4
46
44.2
6
6.3
2
14.3
  20-29 yrs
71
33.3
39
37.5
26
27.4
6
42.9
  30-39 yrs
73
34.3
15
14.4
53
55.8
5
35.7
  >40 yrs
15
7.6
4
3.8
10
10.5
1
7.1
Relapse
24
11.3
2
1.9
11
11.6
11
78.6
Stem cell transplantation
14
6.6
0
0
0
0
14
100.0
Cranial irradiation
 
 
 
 
 
 
 
 
  12-15 Gy
2
0.9
 
 
2
2.1
0
0
  18 Gy
28
13.1
 
 
28
28.4
1
7.1
  20-23 Gy
6
2.8
 
 
6
6.3
0
0
  24-30 Gy
62
29.1
 
 
60
63.2
2
14.3
Total body irradiation
 
 
 
 
 
 
 
 
  8-12 Gy 14 6.6         14 100.0

Abbreviations:ALL acute lymphoblastic leukemia, CRT received cranial irradiation in addition to chemotherapy, TBI received total body irradiation in addition to chemotherapy, including three cases who, in addition, received cranial irradiation.